Assessment of the ability of SARS-CoV-2 strains of genetic variants B.1.1 and JN.1 to evade neutralizing antibodies from 2020 and 2023 convalescent patients

Introduction. The SARS-CoV-2 virus is a highly variable pathogen accounted for by random mutations leading to the emergence of new genetic variants. Natural selection of SARS-CoV-2 variants is, among other things, the result of population level immunity impact. To predict the effectiveness of counte...

Descripción completa

Detalles Bibliográficos

Autores principales:	Stepan A. Pyankov, A. V. Zaykovskaya, A. V. Rybel, S. A. Bodnev, O. V. Pyankov
Formato:	Artigo
Lenguaje:	Russo
Publicado:	Sankt-Peterburg : NIIÈM imeni Pastera 2025-11-01
Colección:	Инфекция и иммунитет
Materias:	covid-19 sars-cov-2 coronavirus cytopathic effect antibodies convalescent blood serum neutralization reaction
Acceso en línea:	https://iimmun.ru/iimm/article/viewFile/17915/2250
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!